CD44 and neoplasm: IHC staining of tumor sections revealed stronger cancer stemness markers (anti‐CD44, Twist, and Bmi1) and higher proliferative activity (anti‐Ki67) in tumor lesions stably expressing WT or Q311E (Fig. 5C).